Highbridge Capital Management’s Opko Health OPK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-671,347
Closed -$900K 84
2020
Q1
$900K Sell
671,347
-755,600
-53% -$1.18M 0.1% 69
2019
Q4
$2.1M Buy
1,426,947
+929,824
+187% +$1.56M 0.23% 49
2019
Q3
$1.04M Buy
497,123
+23,925
+5% +$48.9K 0.15% 49
2019
Q2
$1.16M Sell
473,198
-1,041,785
-69% -$2.27M 0.08% 104
2019
Q1
$3.95M Buy
+1,514,983
New +$4.59M 0.12% 175
2017
Q2
Sell
-148,984
Closed -$1.19M 1502
2017
Q1
$1.19M Buy
+148,984
New +$1.25M 0.02% 566
2016
Q3
Sell
-166,049
Closed -$1.55M 1591
2016
Q2
$1.55M Buy
+166,049
New +$1.69M 0.03% 502
2016
Q1
Sell
-214,773
Closed -$2.16M 1729
2015
Q4
$2.16M Sell
214,773
-128,714
-37% -$1.29M 0.03% 495
2015
Q3
$2.89M Buy
+343,487
New +$4.55M 0.04% 439
2014
Q3
Sell
-25,971
Closed -$229K 1319
2014
Q2
$229K Buy
+25,971
New +$227K ﹤0.01% 936
2014
Q1
Sell
-34,764
Closed -$294K 1199
2013
Q4
$294K Buy
+34,764
New +$351K ﹤0.01% 850

Other funds holding OPK

Highbridge Capital Management's OPK Position: Q2 2020 in Review

Highbridge Capital Management sold out of Opko Health (OPK) in Q2 2020, closing a stake of 671,347 shares — an estimated $900K sold.

Highbridge Capital Management first reported a position in OPK in Q4 2013 and held it in 11 quarters. The position peaked at $3.95M in Q1 2019. 210 funds tracked by Wall St. Rank hold OPK as of Q2 2020.

  • Highbridge Capital Management reported no remaining Opko Health position as of Q2 2020 after selling out during the quarter.
  • Highbridge Capital Management sold 671,347 Opko Health shares in Q2 2020, an estimated $900K.
  • Highbridge Capital Management first reported a position in Opko Health in Q4 2013 and held it in 11 quarters.
  • Highbridge Capital Management's Opko Health position peaked at $3.95M in Q1 2019.
  • 210 funds tracked by Wall St. Rank held Opko Health as of Q2 2020.

Based on Highbridge Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.